57,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
29 °P sammeln
  • Broschiertes Buch

The present interdisciplinary study revealed that latex yielding species E. antiquorum has tremendous potential as a second generation feedstock for liquid biofuel production due to its abundant availability, capacity to grow on marginal lands with high water use efficiency and good percentage of extractable biocrude (21.8%).In general limiting factor for the use of latex yielding plants in biofuel production is the lack of systematic studies, low-cost production and processing technologies that efficiently convert biomass into liquid biofuels. The present study highlighted the use of dried…mehr

Produktbeschreibung
The present interdisciplinary study revealed that latex yielding species E. antiquorum has tremendous potential as a second generation feedstock for liquid biofuel production due to its abundant availability, capacity to grow on marginal lands with high water use efficiency and good percentage of extractable biocrude (21.8%).In general limiting factor for the use of latex yielding plants in biofuel production is the lack of systematic studies, low-cost production and processing technologies that efficiently convert biomass into liquid biofuels. The present study highlighted the use of dried phylloclade biomass, for extraction of biocrude in single step, A5/A10 blending of biocrude with neat diesel, its engine performance and reduced emissions as compared to neat diesel. This study has also revealed the antibacterial properties of flavonoids extracted from pure latex. The enzymes hydrolysate resulted in the release of simple sugars from spent residue for subsequent fermentation bySaccharomyces cerevisiae NCIM 3215. Enzyme hydrolysate yielded 22 g/l ethanol. This study was demonstrated an integrated approach for producing liquid biofuels, i.e. biocrude, Biodiesel and Ethanol .
Autorenporträt
Dr. Pradeep Kumar Sake is a Microbiologist from India, who did research in the area of Biofuels. He also demonstrated his ability in the fields of Nano Biotechnology, Bioinformatics, Drug designing and Clinical trials. Till now (April-2016) he published 17 articles in different national and international journals.